Kenya - English - Pharmacy and Poisons Board

ge healthcare as nycoveien 1, p.o.box 4220 nydalen 0401 oslo norway - gadodiamide - solution for injection - gadodiamide 287 mg/ml (equivalent to 0.5mol/ml) - contrast media - magnetic resonance imaging:

Namibia - English - Namibia Medicines Regulatory Council

amersham health south africa - gadodiamide - injection - gadodiamide injection 287mg/ml 5ml

Namibia - English - Namibia Medicines Regulatory Council

amersham health south africa - gadodiamide - injection - gadodiamide injection 287mg/ml 10ml

Namibia - English - Namibia Medicines Regulatory Council

amersham health south africa - gadodiamide - injection - gadodiamide injection 287mg/ml 15ml

Namibia - English - Namibia Medicines Regulatory Council

amersham health south africa - gadodiamide - injection - gadodiamide injection 287mg/ml 20ml

Australia - English - Department of Health (Therapeutic Goods Administration)

bracco pty ltd - gadoteridol -

Australia - English - Department of Health (Therapeutic Goods Administration)

bracco pty ltd - gadoteridol, quantity: 279.3 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; calteridol calcium; trometamol; sodium hydroxide; water for injections - do not freeze (syringe only). prohance is indicated for use in adults and children from 2 years of age for enhancement of magnetic resonance images of intracranial and spinal lesions where there is an abnormal blood-brain barrier or abnormal vascularity. prohance can also be used for whole body mri.

Canada - English - Health Canada

bayer inc - gadopentetate dimeglumine - solution - 469mg - gadopentetate dimeglumine 469mg - other diagnostic agents

Canada - English - Health Canada

bracco imaging canada - gadoteridol - solution - 279.3mg - gadoteridol 279.3mg - other diagnostic agents

Canada - English - Health Canada

bayer inc - gadobutrol - solution - 604.72mg - gadobutrol 604.72mg - other diagnostic agents